Replies to post #323 on Sinovac Biotech Ltd (SVA)

[rawman]

This announcement makes it look pretty positive for the future, but the .10 per share miss, which was announced today, will constrain growth in the share price. I've been in and out of SVA many times over the last five years. It's troubling that they just can't seem to manage costs and pricing to the extent it will deliver a positive financial result. Maybe the EV71 will be the answer. This morning I exited at $3.96 and will sit on the side for awhile.

[surf1944]

6:33AM On The Wires (WIRES) : Sinovac Biotech (SVA) announced that Sinovac Beijing, the main operating subsidiary co of Sinovac, obtained the Certificate of Good Manufacturing Practices for Pharmaceutical Products from the China State and Food Administration for its proprietary vaccines, its Haidian district bulk production plants, and its Changping filing and packaging facility. The GMP certificate is valid for five years starting from April 17, 2013.